2CUREX — 2cureX AB Share News
0.000.00%
Last trade - 00:00- SEK12.00m
- SEK9.90m
Brief: 2cureX Initiates Listing Process On Spotlight Stock Market
Brief: Nasdaq Decides To Delist 2Curex AB
Brief: 2cureX Removed From Trading In Stockholm
Brief: 2cureX Accelerates Reintegration Into Listed Company
Brief: 2CureX Signs Collaboration Deal With StoreMyTumor
Brief: 2Curex Raises About SEK 7.51 Mln Through Share Issue
Brief: 2cureX H2 Operating Loss At SEK 644,000
Brief: Precomb And 2Curex Sign LoI To Explore Strategic Alliance
Brief: 2cureX CEO To Step Down
Brief: 2cureX H2 Pre-Tax Loss Widens To SEK 3.2 Mln
Brief: 2Curex Announces Appointment Of Dan Honeywell As CEO
Brief: 2Curex H1 Loss Before Tax Narrows To SEK 9.6 Mln
Brief: 2Curex EGM To Vote On Sale Of Danish Subsidiary 2Curex AS
Brief: 2Curex Appoints Ole Thastrup As New CEO
Brief: 2curex To Issue 7.5 Mln Shares To Kinled, Sell Unit In Denmark
Brief: 2CureX To Apply For Delisting Of Its Shares On Nasdaq First North Growth Market In Stockholm
Brief: 2cureX FY Revenue SEK 155 Thousand
Brief: 2cureX Appoints Kenneth G. Johansen As Acting CEO
Brief: 2cureX Gets Ethical Approval For HIPEC Clinical Trial